PLx Pharma (PLXP) Tops Q2 EPS by 4c

PLx Pharma (NASDAQ: PLXP) reported Q2 EPS of ($0.52), $0.04 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $483 thousand versus the consensus estimate of $3.53 million.

For earnings history and earnings-related data on PLx Pharma (PLXP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c